Frontlight ResearchEarly access
CompletedPhase 4
Levothyroxine Dosing in Neonatal Congenital Hypothyroidism
Key facts
- Who runs it
- Menoufia University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 101 people enrolled
- Started
- 2 Nov 2025
- Ended
- 20 Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Levothyroxine
- Record updated
- 10 August 2026
Who can take part
- Age
- 0 days to 28 days
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Neonates diagnosed with primary congenital hypothyroidism
- Full-term infants
- Newly diagnosed
- Treatment initiated during the neonatal period
- Written informed parental consent
Who cannot take part
- Previously thyroid hormone therapy
- Serious systemic illness affecting thyroid function
- Central congenital hypothyroidism
- Prematurity
- Major congenital malformations
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized controlled trial compared high-dose and moderate-dose levothyroxine as initial therapy for neonates with primary congenital hypothyroidism. One hundred one infants were randomized to receive either approximately 12.85 or 7.65 µg/kg/day. Thyroid function and dose adjustments were assessed every 2 weeks over the first six weeks of treatment to evaluate efficacy and safety.
The 2 groups in the trial
- High-dose Levothyroxine GroupTreatment being tested
Participants received initial levothyroxine therapy at a mean dose of 12.85 ± 1.12 µg/kg/day
Treatment: Levothyroxine
- Moderate-dose Levothyroxine GroupExisting treatment, for comparison
Participants received initial levothyroxine therapy at a mean dose of 7.65 ± 0.56 µg/kg/day.
Treatment: Levothyroxine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Optimizing Initial Levothyroxine Dosing in Neonates With Congenital Hypothyroidism
- Record updated
- 10 August 2026